Literature DB >> 8760297

Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice.

D C Martin1, U Rüther, O H Sanchez-Sweatman, F W Orr, R Khokha.   

Abstract

The potential of tissue inhibitors of metalloproteinases (TIMPs) to inhibit neoplastic progression has been postulated from studies of genetically manipulated cells. To investigate whether the TIMP-1 expressed in a host tissue suppresses cancer in vivo and to identify the affected stages, we developed transgenic mice with constitutive overexpression or reduction of TIMP-1 in the liver. In double transgenic experiments, the TIMP-1 lines were crossed with a second transgenic line which expresses the Simian Virus 40t/T antigen (TAg). This viral oncogene leads to heritable development of hepatocellular carcinomas with a 100% incidence. Effects of TIMP-1 coexpression on the TAg-induced neoplasms were determined at the tissue and cellular level. Here, we report that overexpression of hepatic TIMP-1 blocked the development of TAg-induced hepatocellular carcinomas. High TIMP-1 levels inhibited not only the later stages in tumor development (growth and angiogenesis), but also events associated with tumor initiation (altered hepatocyte cytology and tissue architecture). We further show that an antisense-mediated reduction of TIMP-1 resulted in a more rapid tumor initiation and progression. These data demonstrate that intrinsic TIMP-1 levels contribute to a tissue's susceptibility to viral oncogene-induced tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760297

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

2.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.

Authors:  A H Baker; A B Zaltsman; S J George; A C Newby
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

3.  Liver acid sphingomyelinase inhibits growth of metastatic colon cancer.

Authors:  Yosuke Osawa; Atsushi Suetsugu; Rie Matsushima-Nishiwaki; Ichiro Yasuda; Toshiji Saibara; Hisataka Moriwaki; Mitsuru Seishima; Osamu Kozawa
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

Review 4.  The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.

Authors:  M D Sternlicht; M J Bissell; Z Werb
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

5.  Proteinases and their inhibitors in liver cancer.

Authors:  Verena Puxbaum; Lukas Mach
Journal:  World J Hepatol       Date:  2009-10-31

6.  Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice.

Authors:  A Pagenstecher; A K Stalder; C L Kincaid; B Volk; I L Campbell
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.

Authors:  A Pagenstecher; A K Stalder; C L Kincaid; S D Shapiro; I L Campbell
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

8.  Gene transfer for the treatment of neovascular ocular disease (an American Ophthalmological Society thesis).

Authors:  John Timothy Stout
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 9.  Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.

Authors:  Kai Breuhahn; Peter Schirmacher
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

10.  Hematopoiesis in mice is extremely resilient to wide variation in TIMP/MMP balance.

Authors:  Peter Haviernik; Maria T Diaz; Eleonora Haviernikova; William Tse; William G Stetler-Stevenson; Kevin D Bunting
Journal:  Blood Cells Mol Dis       Date:  2008-05-19       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.